← Back to Search

Behavioural Intervention

Virtual Reality Program for Cancer

N/A
Recruiting
Led By Michael LaRiviere, MD
Research Sponsored by Abramson Cancer Center at Penn Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

"This trial aims to see if a virtual reality platform can help cancer patients relax before receiving radiation therapy."

Who is the study for?
This trial is for cancer patients who are scheduled to undergo radiation therapy. It's designed to see if using a Virtual Reality (VR) program before the simulation can help them relax.Check my eligibility
What is being tested?
The study is testing a VR platform that aims to promote relaxation in patients about to receive radiation therapy. The focus is on determining whether this technology is practical and helpful in a clinical setting.See study design
What are the potential side effects?
Since the intervention involves non-invasive VR experiences, significant side effects are not anticipated. However, some participants may experience discomfort such as dizziness or nausea from VR use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of a pre-simulation VR platform prior to radiation
Secondary outcome measures
Patient feedback on pre-simulation VR program
Patient situational anxiety prior to and after use of VR program

Trial Design

1Treatment groups
Experimental Treatment
Group I: Virtual Reality ProgramExperimental Treatment1 Intervention
This is a single arm study. All participants will participate in the study intervention, which involves experiencing a virtual reality program.

Find a Location

Who is running the clinical trial?

Abramson Cancer Center at Penn MedicineLead Sponsor
387 Previous Clinical Trials
145,619 Total Patients Enrolled
Michael LaRiviere, MDPrincipal InvestigatorUniversity of Pennsylvania

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the registration process currently ongoing for this clinical trial?

"As indicated on clinicaltrials.gov, this ongoing medical investigation is actively seeking potential participants. The trial's initial posting date was 3/1/2024, with the most recent update occurring on 3/13/2024."

Answered by AI

What is the current number of participants enrolled in this clinical study?

"Affirmative. Information available on clinicaltrials.gov confirms the ongoing recruitment for this research study. The trial was first made public on March 1st, 2024 and most recently revised on March 13th, 2024. It aims to enroll a total of 25 participants from one designated site."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Virtual Reality to Promote Relaxation Prior to Simulation
Michael LaRiviere, MD 2024. "Virtual Reality to Promote Relaxation Prior to Simulation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06318338.
All > Paid Studies Baltimore > Philadelphia
~17 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top